|
Volumn 35, Issue 5 Pt 3, 2000, Pages 128-140
|
Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC RESISTANCE;
COST BENEFIT ANALYSIS;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
ECONOMICS;
ETHICS;
GENE TARGETING;
GENETIC SERVICE;
GENETICS;
GENOTYPE;
HEALTH SERVICES RESEARCH;
HUMAN;
HUMAN GENOME PROJECT;
HUMAN IMMUNODEFICIENCY VIRUS;
PHARMACOGENETICS;
REVIEW;
COST-BENEFIT ANALYSIS;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE, VIRAL;
GENE TARGETING;
GENETIC SERVICES;
GENOTYPE;
HEALTH SERVICES RESEARCH;
HIV;
HUMAN GENOME PROJECT;
HUMANS;
PHARMACOGENETICS;
|
EID: 0011999969
PISSN: 00179124
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (20)
|
References (33)
|